Which Factors Influence the Outcome After Anatomical and Reverse Shoulder Arthroplasty?
Launched by UNIVERSITEIT ANTWERPEN · Feb 3, 2020
Trial Information
Current as of October 15, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking to understand what factors affect how well people recover after shoulder surgery, specifically shoulder arthroplasty (a type of surgery where the shoulder joint is replaced). Researchers will examine various elements before, during, and after the surgery, such as the patient’s overall health, the specifics of the surgery itself, and the recovery process. The goal is to find out how these factors influence important outcomes like shoulder pain, function, and the overall quality of life for patients after the surgery.
To participate in this trial, you need to be an adult (at least 18 years old) and scheduled for your first shoulder arthroplasty. Unfortunately, if you are having a surgery to fix a previous shoulder replacement (called revision surgery), you won’t be eligible. If you join the study, you can expect to share information about your health and experience throughout the surgery and recovery, which will help doctors learn how to improve outcomes for future patients. The trial is currently recruiting participants of all genders and aims to include a wide range of patients to get a better understanding of the factors that play a role in recovery.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adult men and women \>= 18 years of age
- • Scheduled for primary shoulder arthroplasty
- Exclusion Criteria:
- • Revision surgery
About Universiteit Antwerpen
The University of Antwerp is a leading research institution based in Belgium, renowned for its commitment to advancing knowledge and innovation in various scientific fields. With a strong emphasis on interdisciplinary collaboration, the university actively engages in clinical trials that aim to improve healthcare outcomes and enhance understanding of complex medical conditions. The University of Antwerp's dedicated research teams leverage cutting-edge methodologies and state-of-the-art facilities to conduct rigorous studies, ensuring adherence to the highest ethical standards and regulatory requirements. Through its clinical trial initiatives, the university strives to translate research findings into practical applications that benefit patients and contribute to the broader medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Deurne, Antwerp, Belgium
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials